Precision Biosciences (DTIL) Other Accumulated Expenses (2019 - 2026)

Precision Biosciences (DTIL) has reported Other Accumulated Expenses for 8 consecutive years, with $858000.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Accumulated Expenses fell 4.24% year-over-year to $858000.0; the TTM figure through Mar 2026 stood at $858000.0 (down 4.24% YoY), while the FY2025 annual figure was $649000.0, down 34.38% from the prior year.
• Other Accumulated Expenses advanced to $858000.0 in Q1 2026 per DTIL's latest filing, from $649000.0 in the prior quarter.
• Across five years, Other Accumulated Expenses topped out at $2.8 million in Q1 2024 and bottomed at $611000.0 in Q3 2025.
• Historically, Other Accumulated Expenses has averaged $1.3 million across 5 years, with a median of $1.2 million in 2022.
• Annual changes were most pronounced in 2023 — Other Accumulated Expenses surged 220.94% — and 2025, when it tumbled 67.68%.
• Precision Biosciences' Other Accumulated Expenses stood at $745000.0 in 2022, then soared by 220.94% to $2.4 million in 2023, then plunged by 58.64% to $989000.0 in 2024, then slumped by 34.38% to $649000.0 in 2025, then soared by 32.2% to $858000.0 in 2026.
• Business Quant data shows DTIL's Other Accumulated Expenses at $858000.0 in Q1 2026, $649000.0 in Q4 2025, and $611000.0 in Q3 2025.